ALNT three-lens brief
Evidence-based stock research on ALNT. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Underperforming SPY by 22.3pp over 30 days. · Trading >3% below the 50-day MA — short-term weakness.
- Trading >3% below the 50-day MA — short-term weakness.
- Underperforming SPY by 22.3pp over 30 days.
- Analyst mean target $112.60 — 31% above current (5 analysts).
- Reported earnings on 2026-11-04.
- Ex-dividend date 2026-11-18.
ALNT closed at $86.28 (+1.95%) as of 2026-11-12. Market cap: $1.47B. P/E (trailing) 38.9. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $112.60 — 31% above current (5 analysts).. Concerns: trading >3% below the 50-day MA — short-term weakness.; underperforming SPY by 22.3pp over 30 days.. Last quarter: Revenue $164.40M, net income $15.32M, free cash flow $27.30M.
Why three lenses on ALNT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ALNT across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ALNT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ALNT brief"></iframe>